Talk:Sunovion
![]() | This article is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||||||||||||||||||||
Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.
Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.
Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.
|
Fair use rationale for Image:Sepracor logo.gif
Image:Sepracor logo.gif is being used on this article. I notice the image page specifies that the image is being used under fair use but there is no explanation or rationale as to why its use in this Wikipedia article constitutes fair use. In addition to the boilerplate fair use template, you must also write out on the image description page a specific explanation or rationale for why using this image in each article is consistent with fair use.
Please go to the image description page and edit it to include a fair use rationale. Using one of the templates at Wikipedia:Fair use rationale guideline is an easy way to insure that your image is in compliance with Wikipedia policy, but remember that you must complete the template. Do not simply insert a blank template on an image page.
If there is other other fair use media, consider checking that you have specified the fair use rationale on the other images used on this page. Note that any fair use images uploaded after 4 May, 2006, and lacking such an explanation will be deleted one week after they have been uploaded, as described on criteria for speedy deletion. If you have any questions please ask them at the Media copyright questions page. Thank you.BetacommandBot 04:09, 6 June 2007 (UTC)
Brovana
Apparently, Sepracor has developed a drug entitled Brovana with the purpose of fighting COPD. This drug should probably be mentioned in the main article seeing as it constitutes a major drug in the company's pipeline of products. FitzColinGerald 13:45, 6 July 2007 (UTC)
Lunesta article
How is it that the Lunesta article is far more developed than the Sepracor article? FitzColinGerald 07:45, 19 September 2007 (UTC)
NPOV and Extemporaneous Information
This article has recently incurred a large influx of biased and superfluous information. Such material has no place in an encyclopedic article. Examples include:
Apparently the challenging economic times do not apply to him [Adrian Adams - CEO]. He is viewed as an arrogant and dictatorial person. He and upper management at Sepracor are in vast discord with sales and marketing and large numbers of talented individuals have left the company due to the managerial arrogance and dictatorial style.
And,
In view of the string of bad news over the past 24 months and weak sales of its flagship products XOPENEX and LUNESTA, it is another example of managerial duplicity and inimical treatment of the rest of the company. Many wonder how long this managerial impotence and financial obscenity will last.
In referring to Wikipedia's guidelines regarding neutral point of view, one will see that this kind of language is simply unacceptable. FitzColinGerald (talk) 14:11, 28 May 2009 (UTC)
Name Change
Given the company's recent name change, this article should probably be renamed "Sunovion." FitzColinGerald (talk) 18:18, 1 December 2010 (UTC)
Need information on the Omnaris back-order/licensing problem
It would be great if someone with good knowledge of the current problem that is occurring between Takeda/Sunovion/Nycomed on the take-over of Nycomed by Takeda and the problem this has caused with licensing issues surrounding Alvesco and Omnaris, and the resulting lack of supply in the channel, would write up this information. Omnaris has been on back order now for some time and doctors are no longer able to prescribe it and no pharmacies are able to fill orders. I came to Wikipedia hoping to find out more about this issue as it is a somewhat life threatening issue for me, and see nothing. Web searches yield little other than a very inflammatory discussion on cafepharma.com between pharmaceutical reps who seem to think Omnaris and Alvesco will disappear from the market over this flap. Please someone look into this and get this vital information published.
Sunovion - edits
Hello,
I am a Sunovion employee and would like to help update the Wikipedia entry for the company. There are some inaccuracies and additions that are needed that I would like to work with you on to ensure I am updating them properly and according to Wikipedia guidelines.
I look forward to working with you. ThanksSunovionComm (talk) 17:13, 25 November 2019 (UTC)
- Start-Class company articles
- Mid-importance company articles
- WikiProject Companies articles
- Start-Class medicine articles
- Mid-importance medicine articles
- All WikiProject Medicine pages
- Start-Class United States articles
- Mid-importance United States articles
- Start-Class United States articles of Mid-importance
- Start-Class Massachusetts articles
- Mid-importance Massachusetts articles
- WikiProject Massachusetts articles
- WikiProject United States articles